Side population cells in human cancers

Cancer Letters

Volumn 268, Issue 1, 2008, Pages 1-9

  Wu, Colleen ^a   Alman, Benjamin A ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cancer stem cell; Hoechst dye; Side population; Tumor initiating cell

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ABC TRANSPORTER; ABC TRANSPORTER G1; ATAXIN 1; BASIC FIBROBLAST GROWTH FACTOR; BETA CATENIN; BREAST CANCER RESISTANCE PROTEIN; CD34 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD71 ANTIGEN; CELL SURFACE MARKER; DOXORUBICIN; HOE 33342; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; RHODAMINE 123; STEM CELL FACTOR RECEPTOR; VERAPAMIL; WNT PROTEIN;

CANCER STEM CELL; CARCINOGENESIS; CELL CYCLE REGULATION; CELL ISOLATION; CELL POPULATION; CELL STRAIN MCF 7; DRUG CYTOTOXICITY; DRUG RESISTANCE; DRUG TRANSPORT; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENOMIC INSTABILITY; HUMAN; KNOCKOUT MOUSE; MICROARRAY ANALYSIS; NONOBESE DIABETIC MOUSE; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; SHORT SURVEY; SIDE POPULATION CELL; TUMOR XENOGRAFT;

EID: 48349133869     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.03.048     Document Type: Review

References (62)

1. Fialkow P.J. Clonal origin of human tumors. Annu. Rev. Med. 30 (1979) 135-143
2. Vogelstein B., Fearon E.R., Hamilton S.R., and Feinberg A.P. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science 227 (1985) 642-645
3. Heppner G.H. Tumor heterogeneity. Cancer Res. 44 (1984) 2259-2265
4. Hamburger A.W., and Salmon S.E. Primary bioassay of human tumor stem cells. Science 197 (1977) 461-463
5. Bergsagel D.E., and Valeriote F.A. Growth characteristics of a mouse plasma cell tumor. Cancer Res. 28 (1968) 2187-2196
6. Bruce W.R., and VanDerGaag H. A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 199 (1963) 79-80
7. Fidler I.J., and Hart I.R. Biological diversity in metastatic neoplasms: origins and implications. Science 217 (1982) 998-1003
8. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003) 3983-3988
9. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells cancer and cancer stem cells. Nature 414 (2001) 105-111
10. Lobo N.A., Shimono Y., Qian D., and Clarke M.F. The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol. 23 (2007) 675-699
11. Pardal R., Clarke M.F., and Morrison S.J. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 3 (2003) 895-902
12. Hill R.P. Identifying cancer stem cells in solid tumors: case not proven. Cancer Res. 66 (2006) 1891-1895 (discussion 1890)
13. Kern S.E., and Shibata D. The fuzzy math of solid tumor stem cells: a perspective. Cancer Res. 67 (2007) 8985-8988
14. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., and Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 (1994) 645-648
15. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3 (1997) 730-737
16. O'Brien C.A., Pollett A., Gallinger S., and Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 (2007) 106-110
17. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., and De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 445 (2007) 111-115
18. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., and Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63 (2003) 5821-5828
19. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
20. Arndt-Jovin D.J., and Jovin T.M. Analysis sorting of living cells according to deoxyribonucleic acid content. J. Histochem. Cytochem. 25 (1977) 585-589
21. Lalande M.E., and Miller R.G. Fluorescence flow analysis of lymphocyte activation using Hoechst 33342 dye. J. Histochem. Cytochem. 27 (1979) 394-397
22. Challen G.A., and Little M.H. A side order of stem cells: the SP phenotype. Stem Cells 24 (2006) 3-12
23. Goodell M.A., Brose K., Paradis G., Conner A.S., and Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183 (1996) 1797-1806
24. Goodell M.A., Rosenzweig M., Kim H., Marks D.F., DeMaria M., Paradis G., Grupp S.A., Sieff C.A., Mulligan R.C., and Johnson R.P. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat. Med. 3 (1997) 1337-1345
25. Pearce D.J., Ridler C.M., Simpson C., and Bonnet D. Multiparameter analysis of murine bone marrow side population cells. Blood 103 (2004) 2541-2546
26. Larderet G., Fortunel N.O., Vaigot P., Cegalerba M., Maltere P., Zobiri O., Gidrol X., Waksman G., and Martin M.T. Human side population keratinocytes exhibit long-term proliferative potential and a specific gene expression profile and can form a pluristratified epidermis. Stem Cells 24 (2006) 965-974
27. Yano S., Ito Y., Fujimoto M., Hamazaki T.S., Tamaki K., and Okochi H. Characterization and localization of side population cells in mouse skin. Stem Cells 23 (2005) 834-841
28. Summer R., Kotton D.N., Sun X., Ma B., Fitzsimmons K., and Fine A. Side population cells and Bcrp1 expression in lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 285 (2003) L97-L104
29. Majka S.M., Beutz M.A., Hagen M., Izzo A.A., Voelkel N., and Helm K.M. Identification of novel resident pulmonary stem cells: form and function of the lung side population. Stem Cells 23 (2005) 1073-1081
30. Shimano K., Satake M., Okaya A., Kitanaka J., Kitanaka N., Takemura M., Sakagami M., Terada N., and Tsujimura T. Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1. Am. J. Pathol. 163 (2003) 3-9
31. Martin C.M., Meeson A.P., Robertson S.M., Hawke T.J., Richardson J.A., Bates S., Goetsch S.C., Gallardo T.D., and Garry D.J. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev. Biol. 265 (2004) 262-275
32. Kim M., and Morshead C.M. Distinct populations of forebrain neural stem progenitor cells can be isolated using side-population analysis. J. Neurosci. 23 (2003) 10703-10709
33. Behbod F., Xian W., Shaw C.A., Hilsenbeck S.G., Tsimelzon A., and Rosen J.M. Transcriptional profiling of mammary gland side population cells. Stem Cells 24 (2006) 1065-1074
34. Meeson A.P., Hawke T.J., Graham S., Jiang N., Elterman J., Hutcheson K., Dimaio J.M., Gallardo T.D., and Garry D.J. Cellular and molecular regulation of skeletal muscle side population cells. Stem Cells 22 (2004) 1305-1320
35. Liadaki K., Kho A.T., Sanoudou D., Schienda J., Flint A., Beggs A.H., Kohane I.S., and Kunkel L.M. Side population cells isolated from different tissues share transcriptome signatures and express tissue-specific markers. Exp. Cell Res. 303 (2005) 360-374
36. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., Lagutina I., Grosveld G.C., Osawa M., Nakauchi H., and Sorrentino B.P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7 (2001) 1028-1034
37. Bunting K.D., Galipeau J., Topham D., Benaim E., and Sorrentino B.P. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 92 (1998) 2269-2279
38. Bunting K.D., Zhou S., Lu T., and Sorrentino B.P. Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood 96 (2000) 902-909
39. Jonker J.W., Freeman J., Bolscher E., Musters S., Alvi A.J., Titley I., Schinkel A.H., and Dale T.C. Contribution of the ABC transporters Bcrp1 and Mdr1a/1b to the side population phenotype in mammary gland and bone marrow of mice. Stem Cells 23 (2005) 1059-1065
40. Patrawala L., Calhoun T., Schneider-Broussard R., Zhou J., Claypool K., and Tang D.G. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res. 65 (2005) 6207-6219
41. Mitsutake N., Iwao A., Nagai K., Namba H., Ohtsuru A., Saenko V., and Yamashita S. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology (2007)
42. Kondo T., Setoguchi T., and Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. USA 101 (2004) 781-786
43. Ho M.M., Ng A.V., Lam S., and Hung J.Y. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 67 (2007) 4827-4833
44. Haraguchi N., Utsunomiya T., Inoue H., Tanaka F., Mimori K., Barnard G.F., and Mori M. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24 (2006) 506-513
45. Chiba T., Kita K., Zheng Y.W., Yokosuka O., Saisho H., Iwama A., Nakauchi H., and Taniguchi H. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44 (2006) 240-251
46. Wang J., Guo L.P., Chen L.Z., Zeng Y.X., and Lu S.H. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res. 67 (2007) 3716-3724
47. Hirschmann-Jax C., Foster A.E., Wulf G.G., Nuchtern J.G., Jax T.W., Gobel U., Goodell M.A., and Brenner M.K. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. USA 101 (2004) 14228-14233
48. Szotek P.P., Pieretti-Vanmarcke R., Masiakos P.T., Dinulescu D.M., Connolly D., Foster R., Dombkowski D., Preffer F., Maclaughlin D.T., and Donahoe P.K. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc. Natl. Acad. Sci. USA 103 (2006) 11154-11159
49. Wu C., Wei Q., Utomo V., Nadesan P., Whetstone H., Kandel R., Wunder J.S., and Alman B.A. Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Res. 67 (2007) 8216-8222
50. Hiddemann W., Roessner A., Wormann B., Mellin W., Klockenkemper B., Bosing T., Buchner T., and Grundmann E. Tumor heterogeneity in osteosarcoma as identified by flow cytometry. Cancer 59 (1987) 324-328
51. Reya T., Duncan A.W., Ailles L., Domen J., Scherer D.C., Willert K., Hintz L., Nusse R., and Weissman I.L. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423 (2003) 409-414
52. Willert K., Brown J.D., Danenberg E., Duncan A.W., Weissman I.L., Reya T., Yates III J.R., and Nusse R. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423 (2003) 448-452
53. Zhou J., Wulfkuhle J., Zhang H., Gu P., Yang Y., Deng J., Margolick J.B., Liotta L.A., Petricoin III E., and Zhang Y. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc. Natl. Acad. Sci. USA 104 (2007) 16158-16163
54. Wood L.D., Parsons D.W., Jones S., Lin J., Sjoblom T., Leary R.J., Shen D., Boca S.M., Barber T., Ptak J., Silliman N., Szabo S., Dezso Z., Ustyanksky V., Nikolskaya T., Nikolsky Y., Karchin R., Wilson P.A., Kaminker J.S., Zhang Z., Croshaw R., Willis J., Dawson D., Shipitsin M., Willson J.K., Sukumar S., Polyak K., Park B.H., Pethiyagoda C.L., Pant P.V., Ballinger D.G., Sparks A.B., Hartigan J., Smith D.R., Suh E., Papadopoulos N., Buckhaults P., Markowitz S.D., Parmigiani G., Kinzler K.W., Velculescu V.E., and Vogelstein B. The genomic landscapes of human breast and colorectal cancers. Science 318 (2007) 1108-1113
55. Doyle L.A., and Ross D.D. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22 (2003) 7340-7358
56. Wunder J.S., Healey J.H., Davis A.M., and Brennan M.F. A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer 88 (2000) 2721-2730
57. Montanaro F., Liadaki K., Schienda J., Flint A., Gussoni E., and Kunkel L.M. Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters. Exp. Cell Res. 298 (2004) 144-154
58. Tjandra S.S., Hsu C., Goh I., Gurung A., Poon R., Nadesan P., and Alman B.A. IFN-{beta} signaling positively regulates tumorigenesis in aggressive fibromatosis potentially by modulating mesenchymal progenitors. Cancer Res. 67 (2007) 7124-7131
59. Kelly P.N., Dakic A., Adams J.M., Nutt S.L., and Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science 317 (2007) 337
60. Kennedy J.A., Barabe F., Poeppl A.G., Wang J.C., and Dick J.E. Comment on "Tumor growth need not be driven by rare cancer stem cells". Science 318 (2007) 1722 (author reply 1722)
61. Grady W.M., and Markowitz S. Genomic instability and colorectal cancer. Curr. Opin. Gastroenterol. 16 (2000) 62-67
62. Heng H.H., Stevens J.B., Liu G., Bremer S.W., Ye K.J., Reddy P.V., Wu G.S., Wang Y.A., Tainsky M.A., and Ye C.J. Stochastic cancer progression driven by non-clonal chromosome aberrations. J. Cell. Physiol. 208 (2006) 461-472